Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin vs Cisplatin Chemoradiotherapy in Advanced NPC
NCT03919552Phase 3Recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2018
- Primary completion
- Dec 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in nasopharyngeal carcinoma (NPC), sponsored by Nanfang Hospital, Southern Medical University. Started Jan 2018; status: recruiting.
02
Drugs
carboplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03919552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919552.